Thirty days complication rate following surgery performed for deep-brain-stimulation. |
| |
| Authors: | Jürgen Voges MD Rüdiger Hilker MD Kai Bötzel MD Karl L. Kiening MD Manja Kloss MD Andreas Kupsch MD Alfons Schnitzler MD Gerd‐Helge Schneider MD Ulrich Steude MD Günther Deuschl MD Markus O. Pinsker MP |
| |
| Affiliation: | 1. Departments of Neurology and Stereotactic and Functional Neurology, Albertus‐Magnus University, K?ln, GermanyDepartment of Stereotaxy and Functional Neurosurgery, Albert‐Magnus University K?ln, Kerpenerstr. 62, 50924 K?ln, Germany;2. Departments of Neurology and Stereotactic and Functional Neurology, Albertus‐Magnus University, K?ln, Germany;3. Departments of Neurology and Neurosurgery, Ludwig‐Maximilian‐University, München, Germany;4. Departments of Neurology and Neurosurgery, Ruprecht‐Karls University Heidelberg, Germany;5. Departments of Neurology and Neurosurgery, Charite Hospital, Humboldt University Berlin, Germany;6. Department of Neurology, Heinrich‐Heine University, Düsseldorf, Germany;7. Departments of Neurology and Neurosurgery, Christian Albrechts University Kiel, Germany |
| |
| Abstract: | Serious adverse events (SAEs) during the first 30 postoperative days after stereotactic surgery for Deep-Brain-Stimulation performed in 1,183 patients were retrospectively collected from five German stereotactic centers. The mortality rate was 0.4% and causes for death were pneumonia, pulmonary embolism, hepatopathy, and a case of complicated multiple sclerosis. The permanent surgical morbidity rate was 1%. The most frequently observed SAEs were intracranial hemorrhage (2.2%) and pneumonia (0.6%). Skin infection occurred in 5 of 1,183 patients (0.4%). Surgical complications caused secondary AEs (e.g. pneumonia) preferentially in older patients and in patients treated for Parkinson's disease (PD). Complication rates did not differ among the five centers. |
| |
| Keywords: | stereotaxy deep‐brain‐stimulation complications mortality morbidity |
|
|
